| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.006 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |